Canlyniadau Chwilio - Alexandros Ardavanis

  • Dangos 1 - 13 canlyniadau o 13
Mireinio'r Canlyniadau
  1. 1
    The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression

    The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression gan Kleita Michaelidou, Alexandros Tzovaras, Ioannis Missitzis, Alexandros Ardavanis, Andreas Scorilas

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias

    The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias gan Flora Tzifi, Christina Economopoulou, Dimitrios Gourgiotis, Alexandros Ardavanis, Sotirios G. Papageorgiou, Andreas Scorilas

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients

    Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients gan Andreas Scorilas, Andreas Karameris, Niki Arnogiannaki, Alexandros Ardavanis, P Bassilopoulos, Theoni Trangas, Maroulio Talieri

    Cyhoeddwyd 2001
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Loss of GAS5 tumour suppressor lncRNA: an independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients

    Loss of GAS5 tumour suppressor lncRNA: an independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients gan Margaritis Avgeris, Anastasia Tsilimantou, Panagiotis Levis, Theodoros Tokas, Diamantis C. Sideris, Konstantinos Stravodimos, Alexandros Ardavanis, Andreas Scorilas

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer

    Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer gan Sotirios P. Fortis, Michael Sofopoulos, Nectaria N. Sotiriadou, Christoforos Haritos, Christoforos Vaxevanis, Eleftheria A. Anastasopoulou, Nicole Janssen, Niki Arnogiannaki, Alexandros Ardavanis, Graham Pawelec, Sonia A. Perez, Constantin N. Baxevanis

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Docetaxel Versus Docetaxel Plus Cisplatin As Front-Line Treatment of Patients With Advanced Non—Small-Cell Lung Cancer: A Randomized, Multicenter Phase III Trial

    Docetaxel Versus Docetaxel Plus Cisplatin As Front-Line Treatment of Patients With Advanced Non—Small-Cell Lung Cancer: A Randomized, Multicenter Phase III Trial gan Vassilis Georgoulias, Alexandros Ardavanis, Athina Agelidou, M. Agelidou, Vassilis Chandrinos, Emilia Tsaroucha, Michael Toumbis, Charalambos Kouroussis, Konstantinos Syrigos, Aristidis Polyzos, Nikolaos Samaras, Pavlos Papakotoulas, Charalambos Christofilakis, Nicolaos Ziras, Athanasios Alegakis

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence

    Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence gan Elizabeth A. Mittendorf, Alexandros Ardavanis, Jennifer K. Litton, Nathan M. Shumway, Diane F. Hale, James L. Murray, Sonia A. Perez, Sathibalan Ponniah, Constantin N. Baxevanis, Michael Papamichail, George E. Peoples

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Safety of Cabazitaxel + Prednisone (Cbz + P) in Patients (Pts) with Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Previously Treated with Docetaxel (Doc): Cohort Compassionate-Use Programme (Cup)

    Safety of Cabazitaxel + Prednisone (Cbz + P) in Patients (Pts) with Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Previously Treated with Docetaxel (Doc): Cohort Compassi... gan Axel Heidenreich, H Scholz, Hasan Özen, Choosak Pripatnanont, Inge M. van Oort, Winald R. Gerritsen, Eleni Efstathiou, José Augusto Rinck, Jeong Hyun Lee, A. Boumessous, Zhen Su, Simon Hitier, Alexandros Ardavanis

    Cyhoeddwyd 2014
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Vinorelbine Plus Cisplatin Versus Docetaxel Plus Gemcitabine in Advanced Non-Small-Cell Lung Cancer: A Phase III Randomized Trial

    Vinorelbine Plus Cisplatin Versus Docetaxel Plus Gemcitabine in Advanced Non-Small-Cell Lung Cancer: A Phase III Randomized Trial gan Vassilis Georgoulias, Alexandros Ardavanis, Xanthi Tsiafaki, Athina Agelidou, Penelope Mixalopoulou, Ourania Anagnostopoulou, P. Ziotopoulos, M. Toubis, Kostas Syrigos, Nikolaos Samaras, Aris Polyzos, Anna Christou, Stylianos Kakolyris, Charalambos Kouroussis, Nikolaos Androulakis, George Samonis, Dora Chatzidaki

    Cyhoeddwyd 2005
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence

    Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence gan Elizabeth A. Mittendorf, Alexandros Ardavanis, James T. Symanowski, James L. Murray, Nathan M. Shumway, Jennifer K. Litton, Diane F. Hale, Sonia A. Perez, Eleftheria A. Anastasopoulou, Nikolaos Pistamaltzian, Sathibalan Ponniah, Constantin N. Baxevanis, Eric von Hofe, Michael Papamichail, GE Peoples

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project

    Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) partici... gan John Souglakos, Ioannis Boukovinas, Stylianos Kakolyris, S. Xynogalos, Nikolaos Ziras, A. Athanasiadis, Nikolaos Androulakis, Athina Christopoulou, Michael Vaslamatzis, Alexandros Ardavanis, Christos Emmanouilides, Iliada Bompolaki, C. Kourousis, Paris Makrantonakis, C. Christofyllakis, Elias Athanasiadis, Nikolaos Kentepozidis, Athanasios Karampeazis, U. Katopodi, A. Anagnosopoulos, George K. Papadopoulos, Efthymis Prinarakis, Aggeliki Kalisperi, Dimitriοs Mavroudis, Vassilis Georgoulias

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Breakthrough Cancer Pain: An Observational Study of 1000 European Oncology Patients

    Breakthrough Cancer Pain: An Observational Study of 1000 European Oncology Patients gan Andrew Davies, Alison Buchanan, Giovambattista Zeppetella, Josep Porta-Sales, Rudolf Likar, Wolfgang Weismayr, Ondřej Sláma, Tarja Korhonen, Marilène Filbet, Philippe Poulain, Kyriaki Mystakidou, Alexandros Ardavanis, Tony O’Brien, Pauline Wilkinson, Augusto Caraceni, F Zucco, W. W. A. Zuurmond, Steen Andersen, Anette Damkier, Tove Bahn Vejlgaard, Friedemann Nauck, Lukas Radbruch, Karl‐Fredrik Sjölund, Mariann Stenberg

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence

    Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence gan Tommy A. Brown, Elizabeth A. Mittendorf, Diane F. Hale, John W. Myers, Kaitlin M. Peace, Doreen O. Jackson, Julia M. Greene, Timothy J. Vreeland, Guy T. Clifton, Alexandros Ardavanis, Jennifer K. Litton, Nathan M. Shumway, James T. Symanowski, James L. Murray, Sathibalan Ponniah, Eleftheria A. Anastasopoulou, Nikolaos Pistamaltzian, Constantin N. Baxevanis, Sonia A. Perez, Michael Papamichail, George E. Peoples

    Cyhoeddwyd 2020
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: